Connect with us

Business

From ‘brilliant’ to ‘aghast’: Reactions to RFK Jr.’s nomination for HHS secretary run the gamut

Published

12 minute read

From LifeSiteNews

By Dr. Brenda Baletti, The Defender

From “brilliant” to “aghast” – President-elect Donald J. Trump’s nomination on Thursday of Robert F. Kennedy Jr., founder of Children’s Health Defense (CHD), to run the U.S. Department of Health and Human Services (HHS) triggered a range of reactions among media outlets, public health officials, and Kennedy’s long-time supporters and detractors.

In a statement posted on Truth Social and X, Trump said Kennedy would restore the public health agencies “to the traditions of Gold Standard Scientific Research, and beacons of Transparency, to end the Chronic Disease epidemic, and to Make America Great and Healthy Again!”

Kennedy, who promised to fight corruption and end the revolving door between industry and government, thanked Trump for the nomination on social media. He said he would “free the agencies from the smothering cloud of corporate capture so they can pursue their mission to make Americans once again the healthiest people on Earth.”

 

Kennedy is a longtime critic of how corporate interests have captured the public health agencies meant to regulate them, and of the outsized and corrupt role that Big Pharma plays in American life.

If confirmed, Kennedy would hold the most powerful governmental position in public health, overseeing 80,000 employees across a department that houses 13 agencies and more than 100 programs. Those agencies include the Centers for Disease Control and Prevention (CDC), the U.S. Food and Drug Administration (FDA), the National Institutes of Health and the Center for Medicaid and Medicare Services.

CHD CEO Mary Holland told The Defender the organization “could not be more pleased” with the nomination, adding:

Kennedy has been devoted to ending the childhood chronic health epidemic for almost 20 years. He has been effective in communicating the failures of our existing public health establishment.

Based on his extensive litigation history, he is uniquely prepared to reform the regulatory institutions, the research institutions, and public education on health. I look forward to seeing dramatic, measurable improvements in Americans’ health during the Trump administration.

Democratic Colorado Gov. Jared Polis said on X that he was “excited by the news,” particularly about Kennedy’s commitment to fighting chemicals in foods, the power of Big Pharma, and to other health priorities.

“I hope he leans into personal choice on vaccines rather than bans (which I think are terrible, just like mandates) but what I’m most optimistic about is taking on big pharma and the corporate ag oligopoly to improve our health,” he added.

Rep. Chip Roy (R-Texas) told Fox News, “I think Robert is another disruptor. We need a disruptor. I will be glad and I’m looking forward to working with him,” Politico reported.

Sen. Ron Johnson (R-Wis.) called Kennedy a “brilliant, courageous truth-teller” and said he could make the “most significant impact on health.”

Vaccine stocks take a dive on news of announcement

On the flip side, some lawmakers and public health leaders expressed alarm, decrying the nomination.

U.S. Rep. Robert Garcia (D-Calif.) called the choice “f— insane” on X, Fox News reported. “He’s a vaccine denier and a tin foil hat conspiracy theorist. He will destroy our public health infrastructure and our vaccine distribution systems. This is going to cost lives.”

Dr. Richard E. Besser, CEO of the Robert Wood Johnson Foundation and a former acting director of the CDC, said that having Kennedy head up HHS “would pose incredible risks to the health of the nation,” because Kennedy’s critique of the public health agencies was worsening the mistrust lingering after the coronavirus pandemic, The New York Times reported.

Besser told CNN that some of Kennedy’s ideas about chronic health issues regarding children were good ideas, but other ideas were deeply concerning – particularly Kennedy’s proposal that individuals should decide for themselves whether to take a vaccine.

“The idea that receiving childhood vaccines would be a parental choice scares me,” he said.

READ: Canada’s public health agency still working to adopt WHO pandemic treaty: report

Current CDC Director Mandy Cohen raised concerns that Kennedy would use the position to spread misinformation and foster distrust in public health institutions, particularly with respect to vaccines.

Kennedy has called for an end to immunity for vaccine manufacturers for the injuries caused by their products. He points out that no vaccine on the childhood immunization schedule has undergone proper safety and efficacy testing.

He has been a long-term advocate for the tens of thousands of families seeking compensation for their children’s vaccine-induced autism.

Kennedy also promised that, if confirmed, he would make the V-safe vaccine injury data collected but not made public by the CDC transparent, so scientists have access to the data necessary to analyze vaccine safety

Vaccine and Pharma stocks fell sharply this morning, following yesterday’s announcement about Kennedy, Reuters reported.

 

Bavarian Nordic, which makes the mpox vaccine, was down 16 percent. Its CEO told Reuters he was concerned that Kennedy could fuel vaccine skepticism.

However, he also said that the U.S. response to the COVID-19 pandemic under Trump’s first term made him confident that the incoming administration would continue to fund biodefense.

The Trump administration launched and oversaw Operation Warp Speed, the public-private partnership to rapidly develop a COVID-19 vaccine that gave vaccine makers hundreds of billions in profits along with total immunity for any harms caused by those investigational vaccines under the Public Readiness and Emergency Preparedness (PREP) Act.

Kennedy will be ‘single greatest threat to profits in America’

Republican advisers have cautioned that Kennedy could face a difficult path to confirmation, The Washington Post reported, citing his “past statements on drugs and vaccines, and his many personal entanglements.” FiercePharma said his confirmation process is likely “to be contentious.”

Physician, professor and Substacker Dr. Vinay Prasad wrote that Trump could use a recess appointment to secure Kennedy’s position, but that he will likely need to be confirmed by the Senate where “He has a several hundred billion dollar industry that will do everything possible to stop him.”

“Many of these companies have lobbied throughout Congress,” Prasad added. “They will use those connections. Unlike other controversial appointees, RFK Jr. will be the single greatest threat to profits in America.”

If his appointment goes through, Prasad said Kennedy will face a difficult road in getting his proposed policies enacted, given the entrenched power of Pharma and the power of the media that opposes him.

Law professor Wendy Parmet, director of Northeastern University’s Center for Health Policy and Law, pointed to the potential clash between Kennedy’s anti-industry position and the big-business leanings of the Republican Party.

“We have an administration that promises to deregulate, to be business-friendly, and then we have RFK Jr., who promises to go after fast food,” Parmet told The Washington Post.

READ: Idaho health district votes to stop offering COVID vaccines at its medical centers

Health and health freedom advocates optimistic Kennedy will bring change

Despite the challenges ahead, health advocates are optimistic that changes they have been seeking for decades will come to pass.

During the COVID-19 pandemic, critics of pandemic policies were condemned and marginalized. Kennedy was censored by the Biden administration and social media companies as part of the so-called “Disinformation Dozen” for airing many of those critiques.

Over the course of the election Kennedy – who ran for president as a Democrat, then announced he was running as an independent before suspending his campaign and endorsing Trump – has repeatedly been called a “conspiracy theorist.” Both Kennedy and CHD are routinely dismissed as “anti-vax” for openly discussing the scientific evidence on the link between vaccines and chronic diseases including autism, attention-deficit/hyperactivity disorder or ADHD and other neuropsychiatric and autoimmune disorders, in some children.

Rather than investigating the science, mainstream media mostly insists these links have been “debunked,” without providing any evidence for their claim.

Kennedy has also called for the removal of fluoride from public drinking water, citing recent studies and a landmark federal court decision that show it interferes with children’s brain development – a concern that has even been flagged by some mainstream public health commentators.

His supporters hope these issues will now receive serious public attention that will lead to policy change.

Holland said on X that Kennedy’s nomination came 38 years to the day after the Vaccine Injury Act that gave vaccine manufacturers immunity from liability was signed into law.

Let’s rewrite this one,” she said.

Todayville is a digital media and technology company. We profile unique stories and events in our community. Register and promote your community event for free.

Follow Author

Business

Our energy policies have made us more vulnerable to Trump’s tariffs

Published on

From the Fraser Institute

By Elmira Aliakbari and Jason Clemens

As Donald Trump, who will be sworn in as president on Monday, threatens to impose tariffs on Canadian exports including oil and natural gas, the calls from some Canadian politicians and analysts for greater energy trade diversification grow louder. However, these calls highlight a hard truth—Canada has repeatedly foregone opportunities to reduce our dependence on the United States by cancelling already approved pipelines and failing to approve new pipeline and LNG projects that could have increased our access to global markets.

The U.S. is not just Canada’s largest energy customer—it’s nearly our only customer. In 2023, 97 per cent of crude oil exports and virtually all natural gas exports were sent south of the border. This dependence on the U.S. for exports leaves Canadian producers and the Canadian economy exposed to policy shifts in Washington and even state capitals.

Consider Energy East, a pipeline proposed by TransCanada (now TC Energy) to transport oil from Alberta and Saskatchewan to refineries and export terminals in Atlantic Canada. The pipeline would have reduced Atlantic Canada’s reliance on imported oil and opened export markets for Canadian oil to Europe.

However, in 2017 the Trudeau government introduced new criteria for evaluating and approving major pipeline projects, and for the first time assessments included not only the greenhouse gas (GHG) emissions from constructing the pipeline but also emissions from producing and using the oil it would transport. Later that year, TransCanada suspended its application for the project, effectively cancelling it. The CEO of TransCanada blamed “changed circumstances” but many observers recognized it was a combination of the new regulations and opposition from Quebec, particularly the City of Montreal. Consequently, the refineries in Atlantic Canada continue to rely on imported oil.

A year earlier in 2016, the Trudeau government cancelled the already-approved Northern Gateway pipeline, which would have connected Alberta oil production with the west coast and created significant export opportunities to Asian markets.

Canada is even more dependent on the U.S. for natural gas exports than oil exports. In 2023, Canada exported approximately 84 billion cubic metres of natural gas—all to the U.S.—via 39 pipelines, again leaving producers in Canada vulnerable to U.S. policy changes.

Meanwhile, Canada currently has no operational infrastructure for exporting liquified natural gas (LNG). While LNG Canada, the country’s first LNG export terminal, is expected to become operational this year in British Columbia, it’s long overdue.

Indeed, several energy companies have cancelled or delayed high-profile LNG projects in Canada due largely to onerous regulations that make approvals uncertain or even unlikely, including the $36 billion Pacific NorthWest LNG project in 2017, the $9 billion Énergie Saguenay LNG project in 2020Kitimat LNG in 2021 and East Coast Canada LNG in 2023.

This all adds up to a missed opportunity, as global demand for LNG increases. If governments in Canada allowed or even facilitated more development of LNG facilities, Canadian companies could supply high-demand regions such as Asia and Europe. Indeed, during Europe’s 2022 energy crisis, Germany and several other countries turned to Canada for reliable LNG supply, but the Trudeau government rejected the requests.

The contrast with the U.S. is stark. Since 2011, 18 LNG export facilities have been proposed in Canada but only one—LNG Canada Phase 1—is nearing completion, more than 12 years after it was announced. Meanwhile, as of January 2025, the U.S. has built eight LNG export terminals and approved 20 more, securing its position as a global LNG leader.

Years of inaction and regulatory roadblocks have left Canadian energy producers overly dependent on a single trading partner and vulnerable to shifting U.S. policies. The looming threat of tariffs should be a wake-up call. To secure its energy future, Canada must address the regulatory barriers that have long hindered progress and prioritize the development of infrastructure to connect our energy resources to global markets.

Elmira Aliakbari

Director, Natural Resource Studies, Fraser Institute

Jason Clemens

Executive Vice President, Fraser Institute
Continue Reading

Business

FDA bans commonly used food dye

Published on

FDA Finally Bans Cancer-Linked Red No. 3 Food Dye

By Nicolas Hulscher, MPH

The Food and Drug Administration (FDA) announced on Wednesday that it is banning the use of Red No. 3, a synthetic dye responsible for the vibrant cherry red color in foods and beverages, citing its association with cancer in animal studies:

The dye is still used in thousands of foods, including candy, cereals, cherries in fruit cocktails and strawberry-flavored milkshakes, according to the Center for Science in the Public Interest, a food safety advocacy group that petitioned the agency in 2022 to end its use.

Food manufacturers will have until Jan. 15, 2027 to reformulate their products. Companies that make ingested drugs, such as dietary supplements, will get an additional year.

This ban was LONG overdue. Unfortunately, the other synthetic food dyes that have also been linked to serious deleterious health effects still remain on the market. A few months ago, I summarized the harm linked to synthetic food dyes — outdated FDA standards expose Americans to toxic food dyes linked to cancer, neurobehavioral issues, and other health risks, demanding urgent regulatory action:

Synthetic Food Dyes: A Half-Century of Harm

·
November 25, 2024
Synthetic Food Dyes: A Half-Century of Harm
 

by Nicolas Hulscher, MPH

 

Read full story

Batada et al found that nearly half (43.2%) of grocery store products contained artificial food colorings (AFCs), with Red 40 (29.8%), Blue 1 (24.2%), Yellow 5 (20.5%), and Yellow 6 (19.5%) being the most common. Candies (96.3%), fruit-flavored snacks (94%), and drink mixes/powders (89.7%) had the highest prevalence of AFCs, while produce contained none.

Oliveira et al summarized the deleterious health effects linked to synthetic food colorings in children: neurobehavioral disordersallergic reactionscarcinogenic and mutagenic potentialgastrointestinal and respiratory issuestoxicitydevelopmental and growth delays, and behavioral changes.

Sultana et al illustrated the specific health hazards associated with particular synthetic food dyes:

Miller et al conducted a systematic review of the potential neurobehavioral impacts (activity and attention) of food dye consumption. They included 27 clinical trials of children exposed to synthetic food dyes and found that 16 of 25 challenge studies (64%) demonstrated evidence of a positive association, with 13 studies (52%) reporting statistically significant findings. The authors concluded, “Current evidence from studies in humans, largely from controlled exposure studies in children, supports a relationship between food dye exposure and adverse behavioral outcomes in children, both with and without pre-existing behavioral disorders.” They also noted that:

“Animal toxicology studies were used by FDA as the basis for regulatory risk assessments of food dyes [25]. All current dye registrations were made between 1969 and 1986 based on studies performed 35 to 50 years ago. These studies were not designed to assess neurobehavioral endpoints. Dye registration was accompanied by derivation of an “acceptable daily intake” (ADI) based on these studies. FDA ADIs have not been updated since original dye registration, although there have been several reviews of specific effects since then, the latest in 2011.”

Synthetic food dyes, widely prevalent in U.S. products and lacking nutritional value, rely on outdated FDA approvals despite evidence of widespread toxicity, carcinogenicity, and adverse neurobehavioral effects, strongly warranting urgent regulatory action to protect public health.

While the FDA has finally made a decision that will benefit public health, they are still allowing the dangerous COVID-19 genetic injections to be administered to all individuals aged 6 months and older despite far exceeding criteria for a Class I recall. The immediate removal of unsafe and ineffective gene therapy injections should be the first priority before anything other product bans.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following the McCullough Foundation and Nicolas Hulscher on X (formerly Twitter) for further content.

Continue Reading

Trending

X